Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-16-043350
Filing Date
2016-12-14
Accepted
2016-12-14 17:01:19
Documents
1
Period of Report
2016-12-12

Document Format Files

Seq Description Document Type Size
1 KELLEN FORM 4 12-12-16 OPTION GRANT rdgdoc.html 4  
1 KELLEN FORM 4 12-12-16 OPTION GRANT rdgdoc.xml 4 6181
  Complete submission text file 0001437749-16-043350.txt   7714
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Issuer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3405 ANNAPOLIS LANE SUITE 200 MINNEAPOLIS MN 55447
Business Address
Kellen Scott (Reporting) CIK: 0001490476 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55242 | Film No.: 162051670